lamotrigine has been researched along with Atrophy in 6 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Falling due to startle-induced seizures (SISs) often leads to injury." | 5.37 | Lamotrigine is favourable for startle-induced seizures. ( Fujiwara, T; Ikeda, H; Imai, K; Inoue, Y; Shigematsu, H; Shishido, T; Takahashi, Y; Takayama, R, 2011) |
| "Lamotrigine trial in SPMS was a randomised control trial to assess whether partial blockade of sodium channels has a neuroprotective effect." | 1.39 | Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression. ( Brenner, R; Furby, J; Giovannoni, G; Gnanapavan, S; Grant, D; Hayton, T; Kapoor, R; Leoni, V; Marta, M; Miller, DH; Morant, S; Palace, J; Teunissen, CE, 2013) |
| "Falling due to startle-induced seizures (SISs) often leads to injury." | 1.37 | Lamotrigine is favourable for startle-induced seizures. ( Fujiwara, T; Ikeda, H; Imai, K; Inoue, Y; Shigematsu, H; Shishido, T; Takahashi, Y; Takayama, R, 2011) |
| "With lamotrigine treatment, the patient who had not had surgery had complete cessation of monthly episodes of status epilepticus and a dramatic reduction of generalized tonic-clonic seizures, and the other patient who received lamotrigine had a 50% reduction of her atonic seizures." | 1.30 | Treatment of seizures in subcortical laminar heterotopia with corpus callosotomy and lamotrigine. ( Ko, TS; Lee, JK; Vossler, DG, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gnanapavan, S | 1 |
| Grant, D | 1 |
| Morant, S | 1 |
| Furby, J | 1 |
| Hayton, T | 1 |
| Teunissen, CE | 1 |
| Leoni, V | 1 |
| Marta, M | 1 |
| Brenner, R | 1 |
| Palace, J | 1 |
| Miller, DH | 1 |
| Kapoor, R | 1 |
| Giovannoni, G | 1 |
| Planche, V | 1 |
| Chassin, O | 1 |
| Leduc, L | 1 |
| Regnier, W | 1 |
| Kelly, A | 1 |
| Colamarino, R | 1 |
| Ikeda, H | 2 |
| Imai, K | 1 |
| Shigematsu, H | 1 |
| Shishido, T | 1 |
| Takayama, R | 1 |
| Fujiwara, T | 1 |
| Takahashi, Y | 1 |
| Inoue, Y | 1 |
| Shen, YC | 1 |
| Brown, ES | 1 |
| Wolfshohl, J | 1 |
| Shad, MU | 1 |
| Vazquez, M | 1 |
| Osuji, IJ | 1 |
| Vossler, DG | 1 |
| Lee, JK | 1 |
| Ko, TS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| OxCarbazepine as a Neuroprotective Agent in MS: A Phase 2a Trial[NCT02104661] | Phase 2 | 30 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| Oxygenation and Perfusion in Patients With Acute Migraine Attacks[NCT03536936] | 1,000 participants (Actual) | Observational | 2010-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lamotrigine and Atrophy
| Article | Year |
|---|---|
Attenuation of the effects of corticosteroids on declarative memory with lamotrigine.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Atrophy; Double-Blind Method; Drug Synergi | 2008 |
5 other studies available for lamotrigine and Atrophy
| Article | Year |
|---|---|
Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression.
Topics: Atrophy; Biomarkers; Brain; Clinical Trials, Phase II as Topic; Disease Progression; Female; Humans; | 2013 |
Sturge-Weber syndrome with late onset hemiplegic migraine-like attacks and progressive unilateral cerebral atrophy.
Topics: Adult; Anticonvulsants; Atrophy; Cerebral Cortex; Female; Humans; Lamotrigine; Migraine with Aura; S | 2014 |
Lamotrigine is favourable for startle-induced seizures.
Topics: Activities of Daily Living; Age of Onset; Anticonvulsants; Atrophy; Brain; Child; Drug Eruptions; El | 2011 |
Lamotrigine in motor and mood symptoms of Huntington's disease.
Topics: Antimanic Agents; Atrophy; Caudate Nucleus; Cerebral Cortex; Chorea; Female; Humans; Huntington Dise | 2008 |
Treatment of seizures in subcortical laminar heterotopia with corpus callosotomy and lamotrigine.
Topics: Adult; Anticonvulsants; Atrophy; Brain Diseases; Cerebellum; Child; Choristoma; Corpus Callosum; Ele | 1999 |